Value-Based Agreements in Rare Disease: Focus on Hereditary Amyloid Transthyretin Amyloidosis

The American Journal of Managed Care^® hosted a scientific interchange titled “Value-Based Agreements in Rare Disease” on September 30, 2020. This publication highlights key discussion points and insights from this event.